Keuangan Tempus AI, Inc. (TEM)
NASDAQ · Healthcare · Medical - Healthcare Information Services · Karyawan: 3.800 · CEO: Eric Lefkofsky
- Harga
- $72,22 -7,22%
- Kapitalisasi pasar
- $12,8 M
- Nilai perusahaan
- $13,6 M
- Laporan terakhir
- Q2 '26 diajukan 2026-07-30
- Laporan berikutnya
- 2026-11-02 Estimasi EPS: -$0,09
Valuasi & angka utama
- Kapitalisasi pasar
- $12,8 M EV $13,6 M
- Pendapatan
- $1,43 M 12 bulan terakhir
- Pertumbuhan pendapatan
- +25% Konsensus FY2026
- Margin laba
- -17,8% Laba bersih / pendapatan, TTM
- P/E
- -50,5× Forward -334,5× (FY2026)
- P/S
- 8,9× Harga / penjualan, TTM
- EV / EBITDA
- -150,1× TTM
- Arus kas bebas
- -$273 jt 12 bulan terakhir
- Laba bersih
- -$254 jt 12 bulan terakhir
- Estimasi pendapatan
- $1,6 M Konsensus FY2026
- Laba
- 2026-11-02 Estimasi pendapatan: $409 jt
- Dividen
- – Tanpa dividen
Poin-poin utama
Dihitung dari angka yang dilaporkan - setiap pernyataan menyertakan angka yang mendasarinya.
- Laporan terakhir (2026-07-30): pendapatan melampaui 0,7%, EPS melampaui 72,0%Pendapatan $382 jt vs $380 jt yang diharapkan (+0,7%); EPS -$0,04 vs -$0,14 (+72,0%).
- Pertumbuhan pendapatan melambat: 21,6% yoyPendapatan Q2 '26: $382 jt, rata-rata empat kuartal sebelumnya: 73,3%.
- Margin operasional -19,8% (TTM), dibanding tahun lalu: +4,9 poinLaba operasional tumbuh -20,6%, pendapatan tumbuh 50,4%.
- Capex: 2,5% dari pendapatan (tahun lalu 2,2%)$35,5 jt diinvestasikan dalam 4 kuartal terakhir (+70,2% dibanding tahun sebelumnya). Arus kas bebas: -$273 jt.
- Jumlah saham dilusian naik dalam setahun: 5,2%Saham dilusian pada Q2 '26: 182 jt, setahun sebelumnya: 173 jt.
- Utang neto: $628 jtKas + investasi jangka pendek: $816 jt, utang termasuk sewa: $1,44 M; tahun lalu utang neto: $562 jt.
Kuartal terakhir: Q2 '26
Kuartal berakhir 2026-06-30. Dibandingkan dengan kuartal yang sama tahun lalu dan konsensus analis sebelum laporan.
Kuartal vs tahun lalu
| Q2 '26 | Tahun lalu | Perubahan | |
|---|---|---|---|
| Pendapatan | $382 jt | $315 jt | +21,6% |
| Margin kotor | 64,4% | 62,0% | +2,5 poin |
| Laba operasional | -$75,9 jt | -$61,8 jt | -22,9% |
| Margin operasional | -19,8% | -19,6% | -0,2 poin |
| Laba bersih | $5,64 jt | -$42,8 jt | +113,2% |
| EPS dilusian | $0,03 | -$0,25 | +112,0% |
| Arus kas operasional | -$7,53 jt | $44,2 jt | -117,0% |
| Capex | $11,1 jt | $9,51 jt | +16,6% |
| Arus kas bebas | -$18,6 jt | $34,7 jt | -153,7% |
| R&D | $96,6 jt | $76,1 jt | +26,9% |
| Kompensasi berbasis saham | $54,1 jt | $22,5 jt | +141,0% |
Dilaporkan vs konsensus
2026-07-30| Aktual | Konsensus | vs konsensus | |
|---|---|---|---|
| Pendapatan | $382 jt | $380 jt | +0,7% |
| EPS (basis konsensus) | -$0,04 | -$0,14 | +72,0% |
Dari laporan 2026-07-30 untuk Q2 '26: pendapatan dan EPS yang diperkirakan analis (sering disesuaikan), sehingga bisa berbeda dari EPS laporan keuangan di atas.
EPS vs konsensus
8 laporan terakhirPendapatan
Dari mana uang berasal - menurut lini bisnis dan wilayah, kuartal demi kuartal.
Pendapatan, laba operasional, dan pertumbuhan
kuartalanPendapatan per lini bisnis
bertumpuk, kuartalan| Segmen | Q2 '26 | yoy | Porsi | TTM | TTM yoy | 12 kuartal |
|---|---|---|---|---|---|---|
| Diagnostics | $289 jt | – | 100,0% | – | – |
Margin & struktur biaya
Berapa bagian dari setiap unit pendapatan yang tersisa di tiap tingkat - dan ke mana biaya mengalir.
Margin
kuartalanBiaya sebagai % pendapatan
kuartalanArus kas & alokasi modal
Kas yang dihasilkan, untuk apa kas itu digunakan, dan apa yang sampai ke pemegang saham.
Arus kas operasional, capex, arus kas bebas
kuartalanPenggunaan kas vs arus kas operasional
tahun fiskal4 kuartal terakhir
laporan arus kas- Arus kas operasional
- -$237 jt
- Capex
- -$35,5 jt
- Buyback
- -$3,04 jt
- Dividen
- $0
- Akuisisi
- $4,1 jt
- Utang neto diterbitkan
- $671 jt
- Kompensasi berbasis saham
- $186 jt
- Arus kas bebas
- -$273 jt
- Dikembalikan ke pemegang saham / FCF
- -1,1%
Jumlah saham dan EPS
kuartalan, dilusianNeraca
Likuiditas, investasi, dan utang pada akhir setiap kuartal.
Kas, investasi, dan utang
akhir kuartalValuasi & imbal hasil
Multiple saat ini dibandingkan lima tahun fiskal terakhir perusahaan itu sendiri; target dan peringkat analis.
Multiple dan imbal hasil
TTM vs 5 tahun fiskal| Sekarang | Rata-rata 5 th | Posisi saat ini dalam rentang 5 tahun | |
|---|---|---|---|
| P/E (TTM) | -50,5× | – | – |
| EV / EBITDA | -150,1× | – | – |
| EV / Penjualan | 9,5× | 15,4× | 8,1× – 26,4× |
| Harga / FCF | -46,9× | – | – |
| Harga / Nilai buku | 29,2× | 59,0× 2 dari 5 tahun | 20,9× – 97,1× |
| Imbal hasil FCF | -2,1% | -3,3% | -4,0% – -2,4% |
| Imbal hasil modal yang diinvestasikan | -13,9% | -58,5% | -107,7% – -10,9% |
| Imbal hasil ekuitas | -54,7% | -245,9% | -1.252,8% – 32,1% |
Analis
Target konsensus $72,80 (+0,8%)
rentang $50,00 – $92,00 · peringkat Buy
Prospek
Konsensus analis untuk tahun fiskal mendatang dan implikasinya pada harga saat ini.
Estimasi konsensus
| Tahun fiskal | Pendapatan | Pertumbuhan | EPS | Pertumbuhan | P/E pada harga saat ini | Analis (EPS) |
|---|---|---|---|---|---|---|
| FY2026 | $1,6 M | +25,4% | -$0,22 | +84,7% | -334,5× | 11 |
| FY2027 | $1,97 M | +23,4% | -$0,03 | +87,0% | -2.575,8× | 11 |
| FY2028 | $2,37 M | +20,6% | $0,57 | +2.121,1% | 127,4× | 10 |
| FY2029 | $2,81 M | +18,6% | $1,68 | +196,6% | 43,0× | 4 |
| FY2030 | $3,25 M | +15,6% | $2,88 | +71,4% | 25,1× | 4 |
Laporan keuangan
Setiap baris laporan laba rugi, neraca, dan laporan arus kas - 12 kuartal dan 10 tahun fiskal, sebagai nilai, % pendapatan, atau pertumbuhan.
Semua pos yang dilaporkan
Semua 254 angka yang ditandai Tempus AI, Inc. dalam laporan 10-Q / 10-K terbarunya, dengan label dan definisi resmi SEC - termasuk catatan (sewa, pajak, buyback, karyawan, ...).
| Pos (label SEC) | Kuartal terakhir | Tahun lalu | yoy | FY terakhir | FY sebelumnya | yoy |
|---|---|---|---|---|---|---|
| Accounts Payable, Current | $73,8 jt | $79,3 jt | -6,9% | $82 jt | $53,8 jt | +52,4% |
| Accounts Receivable, after Allowance for Credit Loss, Current | $361 jt | $266 jt | +35,5% | $311 jt | $155 jt | +101,0% |
| Accounts Receivable, Allowance for Credit Loss, Current | $2,79 jt | $1,55 jt | +80,8% | $2,76 jt | $1,14 jt | +141,5% |
| Accounts Receivable, Credit Loss Expense (Reversal) | $230 rb | $309 rb | -25,6% | $2,56 jt | $680 rb | +276,2% |
| Accretion Expense | $31 rb | -$140 rb | +122,1% | $268 rb | $197 rb | +36,0% |
| Accrued Liabilities, Current | $181 jt | $166 jt | +9,3% | $155 jt | $130 jt | +19,1% |
| Accrued Payroll Taxes, Current | $339 rb2025-12-31 | $24,4 jt | -98,6% | $339 rb | $24,4 jt | -98,6% |
| Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | $151 jt | $122 jt | +24,2% | $137 jt | $105 jt | +30,3% |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | -$1,94 jt | $8,45 jt | -123,0% | $902 rb | $94 rb | +859,6% |
| Additional Paid in Capital, Common Stock | $2,97 M | $2,57 M | +15,7% | $2,89 M | $2,21 M | +30,9% |
| Amortization of Debt Discount (Premium) | $1,68 jt | $609 rb | +175,4% | $4,09 jt | $1,38 jt | +195,8% |
| Amortization of Debt Issuance Costs | $108 rb | $175 rb | -38,3% | $484 rb | $510 rb | -5,1% |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 3,55 jt | 906 rb | +291,9% | 17,9 jt | 6,87 jt | +159,9% |
| APIC, Share-based Payment Arrangement, Increase for Cost Recognition | $55,2 jt | $22,5 jt | +145,6% | $125 jt | $534 jt | -76,6% |
| Assets | $2,37 M | $1,63 M | +45,6% | $2,27 M | $926 jt | +145,6% |
| Assets, Current | $1,29 M | $644 jt | +100,4% | $1,17 M | $668 jt | +74,8% |
| Buildings and Improvements, Gross | $1,23 jt | $1,23 jt | 0,0% | $1,23 jt | $0 | – |
| Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | $02025-12-31 | -$93 rb | +100,0% | $0 | $72 rb | -100,0% |
| Capital Expenditures Incurred but Not yet Paid | $1,51 jt | -$140 rb | +1.181,4% | $5,54 jt | $4,29 jt | +29,0% |
| Capitalized Computer Software, Accumulated Amortization | $467 rb | – | – | – | – | – |
| Capitalized Computer Software, Gross | $20,2 jt | – | – | – | – | – |
| Capitalized Computer Software, Net | $19,8 jt | – | – | – | – | – |
| Cash and Cash Equivalents, at Carrying Value | $600 jt | $186 jt | +221,8% | $605 jt | $341 jt | +77,4% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $604 jt | $188 jt | +221,4% | $609 jt | $342 jt | +78,3% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $78,5 jt | $34,7 jt | +126,0% | $268 jt | $175 jt | +52,7% |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | $4,61 jt | -$39,1 jt | +111,8% | -$244 jt | -$706 jt | +65,4% |
| Contingent Consideration Classified as Equity, Fair Value Disclosure | $4,89 jt | $1,1 jt | +342,9% | $4,98 jt | – | – |
| Contract with Customer, Liability, Current | $87,3 jt | $100 jt | -13,2% | $92,7 jt | $76 jt | +22,0% |
| Contract with Customer, Liability, Noncurrent | $22,1 jt | $23,2 jt | -4,9% | $20,4 jt | $6,71 jt | +203,7% |
| Contract with Customer, Liability, Revenue Recognized | $16,2 jt | $23,5 jt | -31,1% | $74 jt | $69,5 jt | +6,5% |
| Convertible Debt, Noncurrent | $188 jt | $226 jt | -17,0% | $209 jt | $168 jt | +24,1% |
| Cost, Depreciation | $3,67 jt | $3,99 jt | -8,2% | $15,1 jt | $14 jt | +8,5% |
| Costs and Expenses | $458 jt | $376 jt | +21,8% | $1,52 M | $1,38 M | +10,1% |
| Current Federal Tax Expense (Benefit) | – | – | – | $0 | $0 | – |
| Current Foreign Tax Expense (Benefit) | – | – | – | $490 rb | $188 rb | +160,6% |
| Current Income Tax Expense (Benefit) | – | – | – | $885 rb | $155 rb | +471,0% |
| Current State and Local Tax Expense (Benefit) | – | – | – | $395 rb | -$33 rb | +1.297,0% |
| Debt Instrument, Unamortized Discount | $4,5 jt | – | – | – | – | – |
| Debt Issuance Costs, Gross | $700 rb | – | – | – | – | – |
| Deferred Federal Income Tax Expense (Benefit) | – | – | – | -$39 jt | $93 rb | -42.071,0% |
| Deferred Federal, State and Local, Tax Expense (Benefit) | – | – | – | -$52,6 jt | $111 rb | -47.459,5% |
| Deferred Income Tax Expense (Benefit) | $0 | $0 | – | -$52,7 jt | $0 | – |
| Deferred State and Local Income Tax Expense (Benefit) | – | – | – | -$13,5 jt | $18 rb | -75.300,0% |
| Deferred Tax Assets, Deferred Income | $8,86 jt2025-12-31 | $19,7 jt | -55,1% | $8,86 jt | $19,7 jt | -55,1% |
| Deferred Tax Assets, Gross | $727 jt2025-12-31 | $519 jt | +40,1% | $727 jt | $519 jt | +40,1% |
| Deferred Tax Assets, in Process Research and Development | $210 jt2025-12-31 | $119 jt | +77,2% | $210 jt | $119 jt | +77,2% |
| Deferred Tax Assets, Net of Valuation Allowance | $127 jt2025-12-31 | $16,2 jt | +685,9% | $127 jt | $16,2 jt | +685,9% |
| Deferred Tax Assets, Operating Loss Carryforwards | $402 jt2025-12-31 | $309 jt | +30,3% | $402 jt | $309 jt | +30,3% |
| Deferred Tax Assets, Other | $17,3 jt2025-12-31 | $1,08 jt | +1.506,7% | $17,3 jt | $1,08 jt | +1.506,7% |
| Deferred Tax Assets, Tax Credit Carryforwards, General Business | $35,9 jt2025-12-31 | $29,2 jt | +22,7% | $35,9 jt | $29,2 jt | +22,7% |
| Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | $27,3 jt2025-12-31 | $26,4 jt | +3,1% | $27,3 jt | $26,4 jt | +3,1% |
| Deferred Tax Assets, Valuation Allowance | $600 jt2025-12-31 | $503 jt | +19,2% | $600 jt | $503 jt | +19,2% |
| Deferred Tax Liabilities, Gross | $128 jt2025-12-31 | $16,5 jt | +676,8% | $128 jt | $16,5 jt | +676,8% |
| Deferred Tax Liabilities, Intangible Assets | $85,7 jt2025-12-31 | – | – | $85,7 jt | – | – |
| Deferred Tax Liabilities, Net | $330 rb2025-12-31 | $234 rb | +41,0% | $330 rb | $234 rb | +41,0% |
| Deferred Tax Liabilities, Other | $2,02 jt2025-12-31 | $1,26 jt | +60,0% | $2,02 jt | $1,26 jt | +60,0% |
| Depreciation | $7,13 jt | $8,35 jt | -14,6% | $32,1 jt | $26,4 jt | +21,6% |
| Depreciation, Nonproduction | $3,46 jt | $4,24 jt | -18,5% | $16,3 jt | $12,2 jt | +33,5% |
| Dividends | – | – | – | $39,3 jt2024-12-31 | $44,5 jt | -11,6% |
| Earnings Per Share, Basic | $0,03 | -$0,25 | +112,0% | -$1,41 | -$6,23 | +77,4% |
Sumber: SEC companyfacts (XBRL setiap 10-Q / 10-K). Kuartal arus kas dihitung dari angka kumulatif tahun berjalan yang ditandai dalam 10-Q. Rincian segmen ditandai dengan dimensi dan ditampilkan di bagian segmen.
Sumber
Laporan keuangan, pendapatan segmen, metrik, dan estimasi distandardisasi dari laporan perusahaan. Laba segmen dan setiap pos yang dilaporkan: SEC EDGAR (XBRL). Laporan yang dibaca: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30
Data per 2026-11-02